ArticleClinical rheumatology2026
The cally index as an indicator of inflammatory burden across clinical phases of familial mediterranean fever.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advanced glycation end products and the CALLY index reflect inflammatory burden in familial Mediterranean fever.Scientific reports · 2026Article
- Attack-Related Anticipatory Anxiety Symptoms in Familial Mediterranean Fever: An Exploratory Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFamilial Mediterranean fever (FMF) is characterised by recurrent inflammatory episodes and persistent subclinical inflammation, which may lead to long-term consequences such as amyloidosis. Several biomarkers have been identified to assess disease activity. The C-reactive protein-albumin-lymphocyte (CALLY) index is a developing biomarker that combines immunological, nutritional, and inflammatory status. This study aimed to evaluate the clinical usefulness of the CALLY index in distinguishing FMF attacks from attack-free periods.
methodsSeventy healthy controls and 128 FMF patients with a diagnosis based on the Livneh criteria were included. Seventy-one individuals were assessed during the attack-free period, while 57 patients were evaluated during an attack. Clinical characteristics, inflammatory markers, and laboratory data were compared between groups. Multivariate logistic regression analysis was performed to identify independent predictors of FMF attacks. Discriminative performance was evaluated using ROC analysis.
resultsPatients with FMF attacks had statistically significantly lower CALLY index and significantly higher inflammatory marker levels compared to those in the attack-free period and the control group. Attack-free FMF patients had significantly lower CALLY index levels than the control group. The CALLY index was negatively correlated with the neutrophil count, erythrocyte sedimentation rate, and the systemic immune-inflammatory index. A lower level of the CALLY index was an independent predictor for FMF attack according to the multivariate logistic regression analysis (p = 0.005, OR = 0.25). According to ROC analysis, the CALLY index demonstrated outstanding diagnostic accuracy for the diagnosis of FMF attack, with an optimal cut-off value of 0.70 (AUC = 0.931, sensitivity 91.2%, specificity 87.3%).
conclusionThe CALLY index is a simple, cost-effective, and reliable biomarker that represents the inflammatory burden in FMF. Its decrease in both the attack and subclinical stages suggests that it can be used to monitor disease activity and identify individuals who may experience inflammation flares. Key Points • The CALLY index is markedly reduced during familial Mediterranean fever attacks compared with attack-free periods and healthy individuals. • Lower CALLY index values are also observed in attack-free patients, suggesting the presence of persistent subclinical inflammation. • The CALLY index independently predicts FMF attacks and shows high discriminative performance for attack identification. • By integrating inflammatory, immunological, and nutritional parameters, the CALLY index offers a practical tool for monitoring disease activity in FMF.
Indexed as
Identifiers
41817889What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.